NanoMab Technology Limited is a privately held biopharmaceutical company in the development of next generation cancer precision medicine. We are developing medicine for fast and specific delivery of radiation to treat cancer. A therapeutic product is made by a camelid antibody labelled with a radioisotope of therapeutic radiation. This therapeutic product is paired with a diagnosis, using the same antibody vector but labelled with a lower radiation radioisotope for imaging. Our goal is to develop a pipeline of therapeutic and diagnostic pairs, using our proprietary platform of camelid antibodies and of labelling radioisotopes onto the antibodies.